Close Menu

The Mayo Clinic is starting a pilot study to sequence patients in an effort to personalize their health care, reports Ian Sample at the Guardian. Patients will either have their entire genome, disease-related genes, or drug metabolism-related genes sequenced. "The project will help managers at the clinic decide whether it makes sense to read and store a patient's whole genome early on, instead of ordering single genetic tests as and when the need arises," Sample says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.